Accelerating Biologic Therapies
with the power of artificial intelligence
Science that evolves how therapies are discovered
EVQLV DEVELOPS ARTIFICIAL INTELLIGENCE ENGINEERED WITH LIFE SCIENCE DATA AND BIOLOGICAL KNOWLEDGE TO ACCELERATE THE SPEED AT WHICH
BIOLOGICS REACH PATIENTS
Our Technology Offerings
DISCOVER NEXT GENERATION LEADS
Design innovators on existing biologics that possess superior characteristics
ACCELERATE EXISTING LEADS
Using a single biologic candidate, generate superior leads and accelerate to IND-enabling in vivo studies
ANTIBODY COMBINATIONS
Generate combinations of antibodies to offer broader epitope coverage
EXPAND IP PROTECTION
Protect assets by computationally developing a patentable genus of biologic candidates
HUMANIZE & CROSS REACTIVITY
Receive species-specific biologics through the combination of machine learning and billions of biological data points
MULTI-SITE MUTAGENESIS
Perform evolutionarily informed, multi-site mutagenesis at scale, across the entire biologic sequence